Kirsten Drejer

Biography

Co-founder and CEO of Symphogen from 2000-2016  Before joining Symphogen, Dr. Drejer held several scientific and managerial positions in Novo Nordisk including four years as Director of Diabetes Discovery, and three years as Corporate Facilitator. Since 2000, co-founder and CEO of Symphogen until September 2016. Dr. Drejer is a Board member of Symphogen, The Fund for Industrial Growth, Bioneer, Bioporto & Lyhne & Co.

Research Interest

Kirsten Drejer has 30 years of experience in the pharmaceutical and biotech industry. She is on the Advisory Board for The Faculty of Pharmaceutical Sciences, University of Copenhagen and  the Entrepreneurship Advisory Board at Copenhagen Business School. She is a  member of the Executive Management group VL-42 and The Danish Academy of Technical Sciences. She is a NOME mentor in Nordic Mentor Network for Entrepreneurship. She was awarded the ‘BiotechBuilder of the Year' prize in 2003, ‘Entrepreneur of the Year, Biotech' in 2007, and portrayed as top women in biotech 2013 by Fierce Biotech